Table 3.
Change of () | Odds ratio of CP formation | ||||
---|---|---|---|---|---|
95% CI | Interaction p-valuea | 95% CI | Interaction p-valuea | ||
Sex | — | — | 0.99 | — | 0.69 |
Female | 1,800 | 5.6 (0.3, 11.0) | — | 1.3 (1.1, 1.5) | — |
Male | 1,592 | 5.6 (, 11.5) | — | 1.2 (1.0, 1.4) | — |
Race | — | — | 0.99 | — | 0.09 |
White | 1,334 | 5.9 (0.8, 11.0) | — | 1.4 (1.2, 1.6) | — |
Nonwhite | 2,058 | 5.9 (, 12.4) | — | 1.1 (0.9, 1.3) | — |
Age at baseline | — | — | 0.25 | — | 0.58 |
1,658 | 3.5 (, 9.0) | — | 1.3 (1.1, 1.5) | — | |
1,734 | 7.8 (2.2, 13.4) | — | 1.4 (1.2, 1.6) | — | |
Smoking | — | — | 0.36 | — | 0.09 |
Never | 1,658 | 3.9 (, 9.5) | — | 1.4 (1.2, 1.6) | — |
Former and current | 1,729 | 7.4 (1.6, 13.1) | — | 1.1 (1.0, 1.3) | — |
Diabetes | — | — | 0.05 | — | 0.11 |
No | 3,067 | 6.5 (2.1, 10.8) | — | 1.2 (1.1, 1.3) | — |
Yes | 325 | (, 12.8) | — | 1.6 (1.2, 2.3) | — |
Hypertension | — | — | 0.91 | — | 0.30 |
No | 1,996 | 5.4 (0.1, 10.7) | — | 1.1 (1.0, 1.3) | — |
Yes | 1,396 | 5.9 (0.0, 11.7) | — | 1.4 (1.2, 1.6) | — |
Statin use | — | — | 0.87 | — | 0.19 |
No | 2,880 | 5.9 (0.3, 11.4) | — | 1.2 (1.1, 1.4) | — |
Yes | 511 | 5.3 (0.0, 10.6) | — | 1.3 (1.1, 1.5) | — |
Presence of carotid plaqueb | — | — | 0.04 | — | 0.79 |
No | 1,792 | 7.9 (2.1, 13.7) | — | 1.2 (1.1, 1.4) | — |
Yes | 1,600 | 0.5 (, 6.3) | — | 1.3 (1.1, 1.5) | — |
Models included age, sex, race/ethnicity, study region, body mass index, smoking status, pack-years, secondhand smoke exposure, alcohol consumption, physical activity, employment status, high-density lipoprotein cholesterol, total cholesterol, statin use, neighborhood socioeconomic status (SES) index, income, education, systolic and diastolic blood pressure, hypertension, antihypertensive medication, and diabetes. Interquartile range (IQR) for within-city . Note: —, no data; CI, confidence interval; CP, carotid plaque; , intima-media thickness of common carotid artery.
p-Value by the F test of the three-way interaction between , study time, and stratification variable.
Presence of carotid plaque at baseline. Subset with no presence of carotid plaque indicate incidence of carotid plaque during follow-up.